Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹8416 Cr.
Stock P/E
31.8
P/B
5.3
Current Price
₹791.9
Book Value
₹ 149
Face Value
1
52W High
₹1535.1
52W Low
₹ 652.8
Dividend Yield
0.76%

Clean Science Overview

Business

Clean Science And Technology Ltd. is an Indian specialty chemical manufacturer. The company is primarily engaged in the manufacturing of functionally critical specialty chemicals such as Performance Chemicals, Pharmaceutical Intermediates, and FMCG Chemicals. They focus on developing innovative and eco-friendly manufacturing processes that are largely backward integrated, allowing for cost-effective production and reduced waste. The core business model revolves around R&D-driven process innovation to produce high-value, niche chemicals for various end-user industries globally. They make money by selling these specialized chemical products to B2B customers in sectors like pharmaceuticals, agrochemicals, plastics, paints, and personal care.

Revenue Mix

The company's product portfolio is broadly categorized into:

Performance Chemicals: Includes MEHQ, BHA, AP, 4-MAP, etc., used as inhibitors, antioxidants, and UV stabilizers in various industrial applications like polymers, paints, and coatings.

Pharmaceutical Intermediates: Products like Guaiacol and its derivatives, crucial raw materials for pharmaceutical active pharmaceutical ingredients (APIs).

FMCG Chemicals: Primarily includes D-Limonene based products and other additives used in consumer goods, flavors, and fragrances.

While specific revenue contributions are not provided here, the company has established global leadership in several niche performance chemicals like MEHQ, BHA, and AP.

Industry

Clean Science operates in the global specialty chemicals industry, which is characterized by niche product markets, strong R&D focus, and high barriers to entry for specific applications. The Indian specialty chemicals sector is growing, benefiting from global supply chain diversification ("China plus one" strategy) and increasing domestic demand. Clean Science holds a leading global position in several of its key products (e.g., MEHQ, BHA, AP), primarily due to its proprietary, cost-effective, and environmentally sustainable manufacturing processes. It competes with both global and domestic specialty chemical players, often differentiating itself through process efficiency and product quality.

MOAT

Clean Science possesses several durable competitive advantages:

Proprietary Process Innovation: The company has developed non-conventional, environmentally friendly, and proprietary manufacturing processes for many of its products, leading to higher yields, lower costs, and reduced waste compared to traditional methods.

Cost Leadership: Resulting directly from its process innovation, Clean Science often has a significant cost advantage over competitors in its niche product categories.

Backward Integration: Strategic backward integration into key raw materials for some products enhances supply chain security, cost control, and quality consistency.

High Switching Costs: For B2B specialty chemicals, customers typically undergo rigorous approval processes, leading to high switching costs once a supplier and product formulation are established.

R&D Focus: Continuous investment in R&D ensures ongoing process improvements and new product development, sustaining its competitive edge.

Growth Drivers

Global Demand for Specialty Chemicals: Increasing demand from various end-user industries (pharmaceuticals, agrochemicals, polymers) globally, especially in emerging markets.

Import Substitution & "China Plus One": India's push for self-reliance and global supply chain diversification can drive demand for domestic specialty chemical manufacturers.

Capacity Expansion: Ongoing and planned capital expenditure projects to increase production capacity for existing and new products.

New Product Development & Diversification: Expansion into new chemical categories and applications, and catering to a broader range of industries like electronics, water treatment, and food additives.

Sustainability Trends: The company's focus on green chemistry and environmentally friendly processes aligns with global sustainability trends, potentially opening new opportunities.

Risks

Raw Material Price Volatility: Fluctuations in the prices and availability of key raw materials can impact margins, despite backward integration efforts.

Intense Competition: While leading in niches, the specialty chemicals market is competitive, with potential threats from new entrants or aggressive pricing by existing players, particularly from China.

Environmental & Regulatory Risks: Stringent environmental regulations and compliance requirements, both domestic and international, can lead to increased operational costs or potential penalties.

Technological Obsolescence: The risk of new technologies or alternative processes emerging that could render current proprietary processes less competitive.

Currency Fluctuations: Being an exporter, the company is exposed to foreign exchange rate movements, which can affect profitability.

End-User Industry Cyclicality: Demand is tied to the health and growth of various end-user industries, making it susceptible to economic slowdowns in those sectors.

Management & Ownership

Clean Science And Technology is a promoter-led company, founded by the Ranka family. The management team has a strong focus on research & development, process engineering, and operational excellence, which has been instrumental in building its niche leadership. The promoters maintain a significant ownership stake, aligning their interests with long-term company performance. Post-IPO, the ownership structure also includes institutional investors and public shareholders.

Outlook

Clean Science And Technology is well-positioned in the growing specialty chemicals sector, benefiting from its strong R&D capabilities and proprietary, cost-efficient manufacturing processes. Its leadership in several niche product categories and ongoing capacity expansions suggest a positive growth trajectory driven by increasing global demand and import substitution trends. However, the company operates in a competitive and somewhat cyclical industry. Key challenges include managing raw material price volatility, navigating evolving environmental regulations, and sustaining its innovation edge against global competitors. The ability to successfully execute expansion plans, diversify its product portfolio, and maintain its cost leadership will be crucial for its sustained performance.

Clean Science Share Price

Live · BSE / NSE · Inception: 2003
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Clean Science Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 195 228 224 238 241 264 243 245 220 249
Other Income 8 14 10 11 5 12 13 7 10 3
Total Income 203 242 234 249 246 276 256 251 229 252
Total Expenditure 108 133 129 148 142 159 143 158 147 153
Operating Profit 94 109 105 101 104 117 113 94 82 99
Interest 0 1 0 0 0 0 0 0 0 0
Depreciation 11 13 16 18 18 17 19 19 19 21
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 83 95 89 83 85 100 95 75 63 78
Provision for Tax 20 25 23 24 20 25 24 19 17 19
Profit After Tax 63 70 66 59 66 74 70 55 46 58
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 63 70 66 59 66 74 70 55 46 58
Adjusted Earnings Per Share 5.9 6.6 6.2 5.5 6.2 7 6.6 5.2 4.3 5.5

Clean Science Profit & Loss

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 241 393 419 0 512 685 936 791 967 957
Other Income 5 11 11 0 26 30 30 41 39 33
Total Income 246 405 430 0 538 715 966 833 1005 988
Total Expenditure 167 257 234 0 253 385 533 459 579 601
Operating Profit 78 148 196 0 285 330 432 374 427 388
Interest 1 0 0 0 0 0 1 1 1 0
Depreciation 8 11 14 0 17 25 36 46 69 78
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 70 137 182 0 267 305 396 327 357 311
Provision for Tax 21 39 43 0 69 76 100 82 92 79
Profit After Tax 49 98 140 0 198 228 295 244 264 229
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 49 98 140 0 198 228 295 244 264 229
Adjusted Earnings Per Share 4.3 8.6 13.1 0 18.7 21.5 27.8 23 24.9 21.6

Clean Science Balance Sheet

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 188 272 342 0 540 768 1010 1203 1416
Minority's Interest 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 10 14 11 0 18 21 26 32 28
Total Current Liabilities 38 41 77 0 102 135 116 236 251
Total Liabilities 236 327 430 0 660 925 1152 1472 1695
Fixed Assets 102 127 166 0 186 296 460 636 715
Other Non-Current Assets 9 8 7 0 79 59 61 101 86
Total Current Assets 125 193 257 0 395 559 630 735 895
Total Assets 236 327 430 0 660 925 1152 1472 1695

Clean Science Cash Flow

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 6 30 9 0 9 9 58 12 10
Cash Flow from Operating Activities 45 85 160 0 193 127 279 236 214
Cash Flow from Investing Activities -18 -95 -106 0 -187 -79 -270 -185 -152
Cash Flow from Financing Activities -5 -11 -55 0 -6 -0 -55 -53 -53
Net Cash Inflow / Outflow 22 -21 -2 0 0 49 -45 -2 10
Closing Cash & Cash Equivalent 30 9 9 0 9 58 12 10 20

Clean Science Ratios

# Mar 2018 Mar 2019 Mar 2020 Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.32 8.62 13.14 0 18.68 21.51 27.78 22.97 24.88
CEPS(Rs) 4.99 9.59 14.43 0 20.3 23.86 31.18 27.29 31.38
DPS(Rs) 3 7.5 9 0 2.5 3.25 5 5 6
Book NAV/Share(Rs) 16.58 24.02 32.2 0 50.81 72.3 94.95 113.02 133.08
Core EBITDA Margin(%) 30.44 34.74 44.26 0 50.58 43.83 43.01 42 40.14
EBIT Margin(%) 29.18 34.8 43.58 0 52.23 44.57 42.34 41.41 36.99
Pre Tax Margin(%) 28.95 34.72 43.48 0 52.16 44.5 42.28 41.25 36.9
PAT Margin (%) 20.15 24.83 33.3 0 38.71 33.36 31.54 30.83 27.35
Cash Profit Margin (%) 23.28 27.64 36.57 0 42.07 37 35.4 36.63 34.5
ROA(%) 20.71 34.66 36.87 0 36.41 28.84 28.43 18.6 16.7
ROE(%) 26.03 42.47 45.47 0 45 34.95 33.23 22.09 20.22
ROCE(%) 37.58 59.11 59 0 60.5 46.65 44.55 29.62 27.3
Receivable days 59.65 46.14 56.41 0 51.31 60.69 58.46 71.46 69.31
Inventory Days 43.67 30.66 31.17 0 31.16 37.58 38.41 53.6 51.56
Payable days 84.98 51.96 81.94 0 142.77 132.49 102.25 122.63 106.46
PER(x) 0 0 0 0 0 92.65 45.51 57.83 46.91
Price/Book(x) 0 0 0 0 0 27.57 13.32 11.75 8.77
Dividend Yield(%) 0 0 0 0 0 0.16 0.4 0.38 0.51
EV/Net Sales(x) -0.11 -0.01 -0.01 0 -0.01 30.8 14.34 17.82 12.81
EV/Core EBITDA(x) -0.35 -0.04 -0.03 0 -0.02 63.9 31.04 37.73 29.03
Net Sales Growth(%) 0 63.13 6.62 0 22.21 33.66 36.64 -15.42 22.13
EBIT Growth(%) 0 93.28 33.51 0 46.46 14.05 29.8 -17.27 9.09
PAT Growth(%) 0 99.72 42.98 0 42.07 15.18 29.18 -17.33 8.35
EPS Growth(%) 0 99.72 52.45 0 42.1 15.18 29.16 -17.34 8.33
Debt/Equity(x) 0 0.01 0.01 0 0 0 0 0 0
Current Ratio(x) 3.31 4.68 3.34 0 3.87 4.15 5.46 3.11 3.56
Quick Ratio(x) 2.54 3.78 2.89 0 3.36 3.49 4.52 2.59 2.97
Interest Cover(x) 125.56 411.02 443.51 0 820.94 687.48 710.02 257.48 424.67
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +22% +12%
Operating Profit CAGR +14% +9%
PAT CAGR +8% +5%
Share Price CAGR -49% -18%
ROE Average +20% +25% +31% +34%
ROCE Average +27% +34% +42% +46%

Clean Science Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 51.29 %
FII 13.39 %
DII (MF + Insurance) 17.16 %
Public (retail) 48.71 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 74.9874.9874.9874.9774.9774.9774.9750.9750.9651.29
FII 5.925.886.065.835.986.076.2111.141013.39
DII 5.145.044.554.775.465.765.9218.9819.7717.16
Public 25.0225.0225.0225.0325.0325.0325.0349.0349.0448.71
Others 0000000000
Total 100100100100100100100100100100

Clean Science Peer Comparison

Chemicals Edit Columns

Clean Science Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Clean Science Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 25%
  • Debtor days have improved from 122.63 to 106.46days.
  • Company is almost debt free.

Cons

  • Stock is trading at 5.3 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp